Literature DB >> 9419177

Granulocyte-macrophage colony-stimulating factor induces activation and restores respiratory burst activity in monocytes from septic patients.

M A Williams1, S A White, J J Miller, C Toner, S Withington, A C Newland, S M Kelsey.   

Abstract

Monocyte activation in response to recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) was examined in vitro in septic shock patients. These monocytes exhibited a greater respiratory burst activity than monocytes from healthy subjects; the response to secondary stimulation with bacterial stimuli was attenuated. GM-CSF restored the ability of monocytes to respond appropriately to secondary stimulation. Expression of certain integrin adhesion molecules, L-selectin, and Fcgamma receptors was increased on monocytes of septic shock patients; expression of CD11c was reduced. GM-CSF up-regulated integrin expression and decreased L-selectin, FcgammaRII, and FcgammaRIII expression. Septic patients exhibited greater biologic activity of monocyte tissue factor than did healthy subjects. Priming monocytes with GM-CSF accelerated tissue factor activation following stimulation with lipopolysaccharide and bacterial culture supernatant. Certain parameters of monocyte function may be restored by exposure to GM-CSF. This benefit may be offset by an increase in monocyte procoagulant activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9419177     DOI: 10.1086/513802

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

Review 1.  Sepsis-induced immunosuppression: from bad to worse.

Authors:  R C Reddy; G H Chen; P K Tekchandani; T J Standiford
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Disruption of the transcription factor Nrf2 promotes pro-oxidative dendritic cells that stimulate Th2-like immunoresponsiveness upon activation by ambient particulate matter.

Authors:  Marc A Williams; Tirumalai Rangasamy; Stephen M Bauer; Smruti Killedar; Matthew Karp; Thomas W Kensler; Masayuki Yamamoto; Patrick Breysse; Shyam Biswal; Steve N Georas
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 3.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

4.  Diversity of interferon gamma and granulocyte-macrophage colony-stimulating factor in restoring immune dysfunction of dendritic cells and macrophages during polymicrobial sepsis.

Authors:  Stefanie B Flohé; Hemant Agrawal; Sascha Flohé; Meenakshi Rani; Jörg M Bangen; F Ulrich Schade
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

5.  Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?

Authors:  Sara E Perry; Sobhy M Mostafa; Richard Wenstone; Alan Shenkin; Paul J McLaughlin
Journal:  Intensive Care Med       Date:  2003-05-28       Impact factor: 17.440

Review 6.  Immune response of severely injured patients--influence of surgical intervention and therapeutic impact.

Authors:  S Flohé; S B Flohé; F U Schade; C Waydhas
Journal:  Langenbecks Arch Surg       Date:  2007-06-29       Impact factor: 3.445

Review 7.  Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets?

Authors:  Devyn D Gillette; Susheela Tridandapani; Jonathan P Butchar
Journal:  Front Cell Infect Microbiol       Date:  2014-02-21       Impact factor: 5.293

Review 8.  Is There a Role for Hematopoietic Growth Factors During Sepsis?

Authors:  Benjamin G Chousterman; Marine Arnaud
Journal:  Front Immunol       Date:  2018-06-21       Impact factor: 7.561

Review 9.  Immunosenescence: A Critical Factor Associated With Organ Injury After Sepsis.

Authors:  Xuan Lu; Yun-Mei Yang; Yuan-Qiang Lu
Journal:  Front Immunol       Date:  2022-07-18       Impact factor: 8.786

10.  The Effects of Ex Vivo Administration of Granulocyte-Macrophage Colony-Stimulating Factor and Endotoxin on Cytokine Release of Whole Blood Are Determined by Priming Conditions.

Authors:  A Nierhaus; J Linssen; M S Winkler; D P Frings; S Kluge
Journal:  Biomed Res Int       Date:  2017-12-14       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.